Key industry veterans who led the establishment of Samsung and Lotte Biologics have joined HLB to accelerate global drug commercialization and manufacturing efficiency.
Former Samsung and Lotte Bio Executives Reunite at HLB to Drive Commercialization
Key industry veterans who led the establishment of Samsung and Lotte Biologics have joined HLB to accelerate global drug commercialization and manufacturing efficiency.

MTIMES Global Editorial Statement
This analysis is provided for international business intelligence and informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. For inquiries regarding licensing or syndication, please contact [email protected].






